,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2012-05-09 21:06:00,"The Clorox Company ( CLX ), one of the world's leading manufacturers of consumer products, posted its third-quarter 2012 results on Wednesday, 2 nd May.",0.8224504590034485,0.017476866021752357,0.1600726693868637,positive,0.8049736022949219
1,2012-05-09 21:06:00,"Therefore, the analysts had just over a week to ponder over the results.",0.04686881974339485,0.280542254447937,0.6725888848304749,neutral,-0.23367343842983246
2,2012-05-09 21:06:00,"In the subsequent paragraphs, we will cover the recent earnings announcement, analysts' estimate revisions as well as the Zacks Rank and long-term recommendation on the stock.",0.01541630644351244,0.007070785388350487,0.9775128960609436,neutral,0.008345521055161953
3,2012-05-09 21:06:00,Clorox posted third-quarter 2012 earnings per share of $1.05 compared with $1.03 earned in the prior-year quarter.,0.6136199235916138,0.3590254783630371,0.027354581281542778,positive,0.25459444522857666
4,2012-05-09 21:06:00,"However, considering foreign exchange impact, quarterly earnings came in at $1.04 per share, above the Zacks Consensus Estimate of $1.03.",0.873185396194458,0.09342531114816666,0.03338935226202011,positive,0.7797600626945496
5,2012-05-09 21:06:00,"During the quarter, the company's earnings benefited from the ongoing cost-saving initiatives and price increases, while higher raw material, manufacturing and logistics costs, poor product and country mix, and spends on Information Technology (IT) systems and research & development (R&D) facilities were minor deterrents.",0.6276716589927673,0.3097926378250122,0.06253571063280106,positive,0.3178790211677551
6,2012-05-09 21:06:00,"Clorox's net sales during the quarter were up 7% year over year to $1,401 million from $1,304 million in the year-ago quarter, driven by volume growth, contributions from new businesses acquired earlier in the year as well as strength across all of the company's reportable segments.",0.9596855044364929,0.020806530490517616,0.019508013501763344,positive,0.9388789534568787
7,2012-05-09 21:06:00,Revenue also benefited from price increases across the board.,0.9475563168525696,0.017641056329011917,0.03480268269777298,positive,0.9299152493476868
8,2012-05-09 21:06:00,"Total revenue also surpassed the Zacks Consensus Estimate of $1,352 million.",0.9463692903518677,0.019247865304350853,0.03438277170062065,positive,0.9271214008331299
9,2012-05-09 21:06:00,"Looking ahead, the company adjusted its annual sales growth guidance for fiscal 2012 to 4%, against the company's previous guidance range of 2% - 4%.",0.9076826572418213,0.031277064234018326,0.061040278524160385,positive,0.8764055967330933
10,2012-05-09 21:06:00,"The revised guidance reflected betterment in the U.S. categories as well as robust results on the back of innovation, price increase and merchandising initiatives.",0.9553217887878418,0.017296208068728447,0.027381939813494682,positive,0.9380255937576294
11,2012-05-09 21:06:00,"However, gross margin guidance for 2012 was revised to reflect a decline of 125 - 150 basis points compared with its previous guidance of 50 - 75 basis points, due to the continued adverse impact of product and country mix.",0.02059101313352585,0.9678564071655273,0.011552651412785053,negative,-0.9472653865814209
12,2012-05-09 21:06:00,"Therefore, Clorox continues to anticipate annual earnings of $4.00 to $4.10 per share in fiscal 2012.",0.7803772687911987,0.01653393730521202,0.20308879017829895,positive,0.7638433575630188
13,2012-05-09 21:06:00,"For fiscal 2012, Clorox expects to generate free cash flow of about 9% of sales.",0.4062170684337616,0.012953422963619232,0.5808295011520386,neutral,0.39326363801956177
14,2012-05-09 21:06:00,"Additionally, the company also rolled out its fiscal 2013 guidance, projecting sales growth in the range of 2% - 4%.",0.8988375067710876,0.013905392028391361,0.08725707232952118,positive,0.8849321007728577
15,2012-05-09 21:06:00,"Operating income margin for fiscal 2013 is expected to be flat, on the back of a moderate expansion in gross margin, offset by increased administrative expenses.",0.026480743661522865,0.9526710510253906,0.020848212763667107,negative,-0.9261903166770935
16,2012-05-09 21:06:00,The company expects cost containment efforts and price hikes to offset increasing commodities and other manufacturing costs.,0.9090680480003357,0.019361447542905807,0.0715705081820488,positive,0.8897066116333008
17,2012-05-09 21:06:00,"Moreover, the company anticipates fiscal 2013 earnings per share to be in the range of $4.20 - $4.35.",0.11443882435560226,0.01443265751004219,0.8711285591125488,neutral,0.10000616312026978
18,2012-05-09 21:06:00,"The analysts portrayed mixed sentiments for fourth-quarter 2012 while for first-quarter 2013, a negative sentiment is witnessed among them.",0.022352002561092377,0.9388840794563293,0.038763850927352905,negative,-0.9165320992469788
19,2012-05-09 21:06:00,"Over the last 7 days, 6 out of 14 analysts revisited their estimates, of which 4 analysts lowered their estimates for fourth-quarter 2012, while 2 analysts adjusted it in the upward direction.",0.036907948553562164,0.9224016070365906,0.04069044440984726,negative,-0.8854936361312866
20,2012-05-09 21:06:00,"For the first quarter of fiscal 2013, 5 out of 8 analysts covering the stock lowered their estimates over the last 7 days, while no movement was witnessed in the opposite direction.",0.021555976942181587,0.9516546130180359,0.026789385825395584,negative,-0.9300986528396606
21,2012-05-09 21:06:00,"Over the last 7 days, 2 analysts reduced their estimates for fiscal 2012, while for fiscal 2013, 1 analyst lowered the same.",0.017507052049040794,0.9556489586830139,0.026844017207622528,negative,-0.9381418824195862
22,2012-05-09 21:06:00,"With no major movement in estimate revision seen over the past one week, the Zacks Consensus Estimate for fiscal 2012 remained stable at $4.06 per share, while for fiscal 2013 it moved down by a penny to $4.28 per share.",0.02661960944533348,0.9423735737800598,0.031006913632154465,negative,-0.915753960609436
23,2012-05-09 21:06:00,"For the fourth quarter of fiscal 2012, the Zacks Consensus Estimate remained stagnant at $1.28 per share, over the last 7 days.",0.02931942418217659,0.891404926776886,0.07927559316158295,negative,-0.8620855212211609
24,2012-05-09 21:06:00,"However, for first-quarter 2013, analysts moved down their estimates by 5 cents to $1.00 per share.",0.027763614431023598,0.9071360230445862,0.06510040163993835,negative,-0.8793724179267883
25,2012-05-09 21:06:00,"We believe Clorox's conservative gross margin outlook for fiscal 2012, has prompted analysts to revise their estimates accordingly.",0.4252670109272003,0.17006376385688782,0.40466925501823425,positive,0.2552032470703125
26,2012-05-09 21:06:00,"Similarly, after considering Clorox's year-over-year flat operating margin projection and earnings forecast for fiscal 2013, analysts have lowered their estimates for first-quarter and fiscal 2013 to better align with the company's guidance.",0.017335547134280205,0.9607312083244324,0.021933259442448616,negative,-0.9433956742286682
27,2012-05-09 21:06:00,"Clorox is making intensive capital investments in information technology systems and capabilities, particularly in the international market and R&D facilities to boost productivity while providing platforms for growth, product innovation and cost savings.",0.856605052947998,0.0106852687895298,0.13270968198776245,positive,0.8459197878837585
28,2012-05-09 21:06:00,The company believes that these initiatives will begin delivering benefits later in fiscal 2014 and beyond.,0.797470211982727,0.011862308718264103,0.1906675398349762,positive,0.7856078743934631
29,2012-05-09 21:06:00,"Clorox faces intense competition from other well-established consumer product companies, both in the U.S. and international markets.",0.5733254551887512,0.05480704456567764,0.3718675374984741,positive,0.5185183882713318
30,2012-05-09 21:06:00,"Most of the company's products compete with other widely advertised brands within each product category and private label brands and generic non-branded products of grocery chains and wholesale cooperatives in certain categories, which typically are sold at lower prices.",0.04481123015284538,0.02004513144493103,0.9351436495780945,neutral,0.024766098707914352
31,2012-05-09 21:06:00,The main competitors of Clorox are Colgate-Palmolive Company ( CL ) and Procter and Gamble Company ( PG ).,0.013407453894615173,0.011033873073756695,0.9755586981773376,neutral,0.0023735808208584785
32,2012-05-09 21:06:00,"Currently, Clorox has a Zacks #4 Rank, implying a short-term Sell rating.",0.28168582916259766,0.019078826531767845,0.6992353796958923,neutral,0.26260700821876526
33,2012-05-09 21:06:00,"However, we have a long-term Neutral recommendation on the stock.",0.02976071834564209,0.04136376827955246,0.9288755059242249,neutral,-0.01160304993391037
34,2012-05-09 21:06:00,To read this article on Zacks.com click here.,0.017961200326681137,0.01924508437514305,0.9627937078475952,neutral,-0.001283884048461914
35,2012-05-09 21:06:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.015637893229722977,0.9741575717926025,neutral,-0.0054333265870809555
